Horizon is a global biotechnology company focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases.
Our pipeline is purposeful: We apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. Our mission is personal. Many of us at Horizon, including CEO Tim Walbert, are patients, know a patient or have been impacted by a patient story.
Horizon's global headquarters is in Dublin, and its U.S. headquarters is in Deerfield, Ill. The Company also has offices in Chicago; South San Francisco; Washington, D.C.; Gaithersburg and Rockville, Md., and Mannheim, Germany, as well as a growing presence in Japan.
Data Provided by Refinitiv. Minimum 15 minutes delayed.
May 4, 2022 at 8:00 AM EDT
Horizon Therapeutics First Quarter 2022 Earnings Call
Mar 8, 2022 at 11:10 AM EST
Cowen and Company 42nd Annual Health Care Conference
Mar 1, 2022 at 8:00 AM EST
Horizon Therapeutics Fourth Quarter 2021 Earnings Call
Jan 10, 2022 at 11:15 AM EST
40th Annual J.P. Morgan Healthcare Conference
Jan 6, 2022 at 9:00 AM EST
Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference